Turning Point 2012
A selection of articles from the 2012 issue of Turning Point.
Download this issue for your iPad from iTunes
Download this issue for your Android-based tablet from Google Play
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Turning Point in the mail, please complete this form.
When Dana-Farber decided to build a new cancer care center alongside a scientific research building, the result was a direct connection between the laboratories where new therapies are discovered and the clinics where they’re studied in patients.
A look at the evolution of breast cancer treatment and how targeted techniques are more effective.
Scientists find pathways that control cell growth in endometrial and cervical cancer.
Meet two women who turned to Dana-Farber for cancer treatment, and found clinical trials that allow them to continue to work – and live – as normally as possible.
Our cancer specialists answer questions about breast and cervical cancer screenings and the difference between genetic research in people and in tumors.
New drug for ovarian cancer subtype; how cells specialize; breast cancer and Li Fraumeni syndrome; male hormone in breast tumors; strengthening genetic research.
Turning Point is published for supporters of Dana-Farber's Susan F. Smith Center for Women's Cancers. To learn more about the Susan F. Smith Center and its offerings, call Administrative Director Candace S. Lowe, ScD, at 617-632-2675.
Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Dana-Farber Cancer Institute
Department of Communications
450 Brookline Ave.
Boston, MA 02115